A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.2166033538338
   PubMed Web of Science ®Google Scholar
• Gradishar WJ, Moran MS, Abraham J, et al. NCCN guidelines® insights: breast cancer, Version 4.2021. J Natl Compr Canc Netw. 2021;19(5):484–493.34030128
   PubMed Web of Science ®Google Scholar
• Mamounas EP. Impact of neoadjuvant chemotherapy on locoregional surgical treatment of breast cancer. Ann Surg Oncol. 2015;22(5):1425–1433. doi:10.1245/s10434-015-4406-625727558
   PubMed Web of Science ®Google Scholar
• Golshan M, Cirrincione CT, Sikov WM, et al. Impact of neoadjuvant chemotherapy in stage II-III triple negative breast cancer on eligibility for breast-conserving surgery and breast conservation rates: surgical results from CALGB 40603 (Alliance). Ann Surg. 2015;262(3):434–439. doi:10.1097/SLA.000000000000141726222764
   PubMed Web of Science ®Google Scholar
• De La Cruz LM, McDonald ES, Mick R, et al. Anti-HER2 CD4+ T-helper type 1 immune response is superior to breast MRI for assessing response to neoadjuvant therapy in patients with HER2-positive breast cancer. Ann Surg Oncol. 2017;24(4):1057–1063. doi:10.1245/s10434-016-5651-z27826664
   PubMed Web of Science ®Google Scholar
• Taghizadeh Kermani A, Hosseini S, Fanipakdel A, et al. A randomized clinical trial on the antitumoral effects of low molecular weight heparin in the treatment of esophageal cancer. J Cell Physiol. 2019;234(4):4191–4199. doi:10.1002/jcp.2717730362518
   PubMed Web of Science ®Google Scholar
• Fazilat-Panah D, Vakili Ahrari Roudi S, Keramati A, et al. Changes in Cytokeratin 18 during neoadjuvant chemotherapy of breast cancer: a prospective study. Iran J Pathol. 2020;15(2):117–126. doi:10.30699/ijp.2020.116238.226132215027
   PubMedGoogle Scholar
• Homaei Shandiz F, Fanipakdel A, Forghani MN, et al. Clinical efficacy and side effects of IORT as tumor bed boost during breast-conserving surgery in breast cancer patients following neoadjuvant chemotherapy. Indian J Gynecol Oncol. 2020;18:46. doi:10.1007/s40944-020-00389-5
   Web of Science ®Google Scholar
• Sedighi Pashaki A, Mohammadian K, Afshar S, et al. A randomized, controlled, parallel-group, trial on the effects of melatonin on fatigue associated with breast cancer and its adjuvant treatments. Integr Cancer Ther. 2021;20:1534735420988343. doi:10.1177/153473542098834333543655
   PubMed Web of Science ®Google Scholar
• Salek R, Dehghani M, Mohajeri SA, Talaei A, Fanipakdel A, Javadinia SA. Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: a double blind, randomized clinical trial. Phytother Res. 2021;35:24.
   Web of Science ®Google Scholar
• Liu SV, Melstrom L, Yao K, Russell CA, Sener SF. Neoadjuvant therapy for breast cancer. J Surg Oncol. 2010;101(4):283–291. doi:10.1002/jso.2144620187061
   PubMed Web of Science ®Google Scholar
• Symmans WF, Peintinger F, Hatzis C, et al. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol. 2007;25(28):4414–4422. doi:10.1200/JCO.2007.10.682317785706
   PubMed Web of Science ®Google Scholar
• Ogston KN, Miller ID, Payne S, et al. A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast. 2003;12(5):320–327. doi:10.1016/S0960-9776(03)00106-114659147
   PubMed Web of Science ®Google Scholar
• Sheikhbahaei S, Trahan TJ, Xiao J, et al. FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis of diagnostic accuracy studies. Oncologist. 2016;21(8):931–939. doi:10.1634/theoncologist.2015-035327401897
   PubMed Web of Science ®Google Scholar
• Gu YL, Pan SM, Ren J, Yang ZX, Jiang GQ. Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis. Clin Breast Cancer. 2017;17(4):245–255. doi:10.1016/j.clbc.2016.12.01028209330
   PubMed Web of Science ®Google Scholar
• Amioka A, Masumoto N, Gouda N, et al. Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy. Jpn J Clin Oncol. 2016;46(4):303–309. doi:10.1093/jjco/hyv21526848078
   PubMed Web of Science ®Google Scholar
• Ma Y, Zhang S, Li J, Li J, Kang Y, Ren W. Comparison of strain and shear-wave ultrasounic elastography in predicting the pathological response to neoadjuvant chemotherapy in breast cancers. Eur Radiol. 2017;27(6):2282–2291. doi:10.1007/s00330-016-4619-527752835
   PubMed Web of Science ®Google Scholar
• Marinovich ML, Macaskill P, Irwig L, et al. Agreement between MRI and pathologic breast tumor size after neoadjuvant chemotherapy, and comparison with alternative tests: individual patient data meta-analysis. BMC Cancer. 2015;15:662. doi:10.1186/s12885-015-1664-426449630
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247. doi:10.1016/j.ejca.2008.10.02619097774
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yamamoto Y, Iwase H. Clinical imaging for the prediction of neoadjuvant chemotherapy response in breast cancer. Chin Clin Oncol. 2020;9(3):31. doi:10.21037/cco-20-1532594748
   PubMed Web of Science ®Google Scholar
• Dummin LJ, Cox M, Plant L. Prediction of breast tumor size by mammography and sonography–A breast screen experience. Breast. 2007;16(1):38–46. doi:10.1016/j.breast.2006.04.00316846736
   PubMed Web of Science ®Google Scholar
• Hieken TJ, Harrison J, Herreros J, Velasco JM. Correlating sonography, mammography, and pathology in the assessment of breast cancer size. Am J Surg. 2001;182(4):351–354. doi:10.1016/S0002-9610(01)00726-711720669
   PubMed Web of Science ®Google Scholar
• Gruber IV, Rueckert M, Kagan KO, et al. Measurement of tumor size with mammography, sonography and magnetic resonance imaging as compared to histological tumor size in primary breast cancer. BMC Cancer. 2013;5(13):328. doi:10.1186/1471-2407-13-328
   Web of Science ®Google Scholar
• Haraldsdóttir KH, Jónsson Þ, Halldórsdóttir AB, Tranberg KG, Ásgeirsson KS. Tumor size of invasive breast cancer on magnetic resonance imaging and conventional imaging (Mammogram/Ultrasound): comparison with pathological size and clinical implications. Scand J Surg. 2017;106(1):68–73. doi:10.1177/145749691663185526929290
   PubMed Web of Science ®Google Scholar
• Vriens BE, de Vries B, Lobbes MB, et al. Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer. Eur J Cancer. 2016;52:67–76. doi:10.1016/j.ejca.2015.10.01026650831
   PubMed Web of Science ®Google Scholar
• Stein RG, Wollschläger D, Kreienberg R; BRENDA Study Group, et al. The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients. BMC Cancer. 16;2016:459. doi:10.1186/s12885-016-2426-727411945
   PubMed Web of Science ®Google Scholar
• Chagpar AB, Middleton LP, Sahin AA, et al. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006;243(2):257–264. doi:10.1097/01.sla.0000197714.14318.6f16432360
   PubMed Web of Science ®Google Scholar
• Keune JD, Jeffe DB, Schootman M, Hoffman A, Gillanders WE, Aft RL. Accuracy of ultrasonography and mammography in predicting pathologic response after neoadjuvant chemotherapy for breast cancer. Am J Surg. 2010;199(4):477–484. doi:10.1016/j.amjsurg.2009.03.01220359567
   PubMed Web of Science ®Google Scholar
• Choi JH, Lim HI, Lee SK, et al. The role of PET CT to evaluate the response to neoadjuvant chemotherapy in advanced breast cancer: comparison with ultrasonography and magnetic resonance imaging. J Surg Oncol. 2010;102(5):392–397. doi:10.1002/jso.2142419877158
   PubMed Web of Science ®Google Scholar
• Swain SM, Sorace RA, Bagley CS, et al. Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res. 1987;47(14):3889–3894.3036348
   PubMed Web of Science ®Google Scholar
• Cocconi G, Di Blasio B, Alberti G, Bisagni G, Botti E, Peracchia G. Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat. 1984;4(4):309–313. doi:10.1007/BF018060446549147
   PubMed Web of Science ®Google Scholar
• Segel MC, Paulus DD, Hortobagyi GN. Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology. 1988;169(1):49–54. doi:10.1148/radiology.169.1.34202823420282
   PubMed Web of Science ®Google Scholar
• Zhang K, Li J, Zhu Q, Chang C. Prediction of pathologic complete response by ultrasonography and magnetic resonance imaging after neoadjuvant chemotherapy in patients with breast cancer. Cancer Manag Res. 2020;12:2603–2612. doi:10.2147/CMAR.S24727932368138
   PubMed Web of Science ®Google Scholar
• Schaefgen B, Mati M, Sinn HP, et al. Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol. 2016;23(3):789–795. doi:10.1245/s10434-015-4918-026467456
   PubMed Web of Science ®Google Scholar
• Baumgartner A, Tausch C, Hosch S, et al. Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast. 2018;39:19–23. doi:10.1016/j.breast.2018.02.02829518677
   PubMed Web of Science ®Google Scholar
• Wan CF, Du J, Fang H, Li FH, Zhu JS, Liu Q. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors. Radiology. 2012;262(2):450–459. doi:10.1148/radiol.1111078922282183
   PubMed Web of Science ®Google Scholar
• Luo J, Chen JD, Chen Q, et al. Predictive model for contrast-enhanced ultrasound of the breast: is it feasible in malignant risk assessment of breast imaging reporting and data system 4 lesions? World J Radiol. 2016;8(6):600–609. doi:10.4329/wjr.v8.i6.60027358688
   PubMedGoogle Scholar
• Bernatik T, Becker D, Neureiter D, et al. Detection of liver metastases–comparison of contrast–enhanced ultrasound using first versus second generation contrast agents. Ultraschall Med. 2003;24(3):175–179. doi:10.1055/s-2003-4006012817311
   PubMed Web of Science ®Google Scholar
• Lee SC, Grant E, Sheth P, et al. Accuracy of contrast-enhanced ultrasound compared with magnetic resonance imaging in assessing the tumor response after neoadjuvant chemotherapy for breast cancer. J Ultrasound Med. 2017;36(5):901–911. doi:10.7863/ultra.16.0506028150325
   PubMed Web of Science ®Google Scholar
• Cao X, Xue J, Zhao B. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer. Ultrasound Med Biol. 2012;38(12):2065–2071. doi:10.1016/j.ultrasmedbio.2012.07.02723062366
   PubMed Web of Science ®Google Scholar
• Jia K, Li L, Wu XJ, Hao MJ, Xue HY. Contrast-enhanced ultrasound for evaluating the pathologic response of breast cancer to neoadjuvant chemotherapy: a meta-analysis. Medicine. 2019;98(4):e14258. doi:10.1097/MD.000000000001425830681622
   PubMed Web of Science ®Google Scholar
• Wang B, Jiang T, Huang M, et al. Evaluation of the response of breast cancer patients to neoadjuvant chemotherapy by combined contrast-enhanced ultrasonography and ultrasound elastography. Exp Ther Med. 2019;17(5):3655–3663.30988749
   PubMed Web of Science ®Google Scholar
• Saracco A, Szabó BK, Tánczos E, Bergh J, Hatschek T. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy. Acta Radiol. 2017;58(4):394–402. doi:10.1177/028418511665832227461224
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim SH, Song BJ, et al. Early prediction of response to neoadjuvant chemotherapy using dynamic contrast-enhanced MRI and ultrasound in breast cancer. Korean J Radiol. 2018;19(4):682–691. doi:10.3348/kjr.2018.19.4.68229962874
   PubMed Web of Science ®Google Scholar
• Ricci P, Cantisani V, Ballesio L, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. Magn Reson Imaging Ultraschall Med. 2007;28(1):57–62. doi:10.1055/s-2006-927226
   Web of Science ®Google Scholar
• Fröhlich E, Muller R, Cui XW, Schreiber-Dietrich D, Dietrich CF. Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion. J Ultrasound Med. 2015;34(2):179–196. doi:10.7863/ultra.34.2.17925614391
   PubMed Web of Science ®Google Scholar
• Hudson JM, Williams R, Tremblay-Darveau C, et al. Dynamic contrast enhanced ultrasound for therapy monitoring. Eur J Radiol. 2015;84(9):1650–1657. doi:10.1016/j.ejrad.2015.05.01326231046
   PubMed Web of Science ®Google Scholar
• Darland DC, D’Amore PA. Blood vessel maturation: vascular development comes of age. J Clin Invest. 1999;103(2):157–158. doi:10.1172/JCI61279916126
   PubMed Web of Science ®Google Scholar
• Wan CF, Liu XS, Wang L, Zhang J, Lu JS, Li FH. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy. Eur J Radiol. 2018;103:118–123. doi:10.1016/j.ejrad.2018.04.00529803376
   PubMed Web of Science ®Google Scholar
• Mayr NA, Yuh WT, Arnholt JC, et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer. J Magn Reson Imaging. 2000;12(6):1027–1033. doi:10.1002/1522-2586(200012)12:6<1027::AID-JMRI31>3.0.CO;2-511105046
   PubMed Web of Science ®Google Scholar
• Dong T. Early response assessed by contrast-enhanced ultrasound in breast cancer patients undergoing neoadjuvant chemotherapy. Ultrasound Q. 2018;34(2):84–87. doi:10.1097/RUQ.000000000000033329420367
   PubMed Web of Science ®Google Scholar
• Nakata N, Ohta T, Nishioka M, et al. Optimization of region of interest drawing for quantitative analysis: differentiation between benign and malignant breast lesions on contrast-enhanced sonography. J Ultrasound Med. 2015;34(11):1969–1976. doi:10.7863/ultra.14.1004226384607
   PubMed Web of Science ®Google Scholar
• Atri M, Hudson JM, Sinaei M, et al. Impact of acquisition method and region of interest placement on inter-observer agreement and measurement of tumor response to targeted therapy using dynamic contrast-enhanced ultrasound. Ultrasound Med Biol. 2016;42(3):763–768. doi:10.1016/j.ultrasmedbio.2015.11.00526712416
   PubMed Web of Science ®Google Scholar
• Lee YJ, Kim SH, Kang BJ, Kim YJ. Contrast-enhanced ultrasound for early prediction of response of breast cancer to neoadjuvant chemotherapy. Ultraschall Med. 2019;40(2):194–204. doi:10.1055/a-0637-160130103213
   PubMed Web of Science ®Google Scholar
• Evans A, Whelehan P, Thompson A, et al. Identification of pathological complete response after neoadjuvant chemotherapy for breast cancer: comparison of greyscale ultrasound, shear wave elastography, and MRI. Clin Radiol. 2018;73(10):910.e1–910.e6. doi:10.1016/j.crad.2018.05.030
   PubMed Web of Science ®Google Scholar
• Evans A, Whelehan P, Thompson A, et al. Prediction of pathological complete response to neoadjuvant chemotherapy for primary breast cancer comparing interim ultrasound, shear wave elastography and MRI. Ultraschall Med. 2018;39(4):422–431. doi:10.1055/s-0043-11158928934812
   PubMed Web of Science ®Google Scholar
• Falou O, Sadeghi-Naini A, Prematilake S, et al. Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography. Transl Oncol. 2013;6(1):17–24. doi:10.1593/tlo.1241223418613
   PubMed Web of Science ®Google Scholar
• Fernandes J, Sannachi L, Tran WT, et al. Monitoring breast cancer response to neoadjuvant chemotherapy using ultrasound strain elastography. Transl Oncol. 2019;12(9):1177–1184. doi:10.1016/j.tranon.2019.05.00431226518
   PubMed Web of Science ®Google Scholar
• Lee SH, Chang JM, Han W, et al. Shear-wave elastography for the detection of residual breast cancer after neoadjuvant chemotherapy. Ann Surg Oncol. 2015;22(Suppl 3):S376–S384. doi:10.1245/s10434-015-4828-126297209
   PubMed Web of Science ®Google Scholar
• Chang JM, Won JK, Lee KB, Park IA, Yi A, Moon WK. Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions. Am J Roentgenol. 2013;201(2):W347–W356. doi:10.2214/AJR.12.1041623883252
   PubMed Web of Science ®Google Scholar
• Itoh A, Ueno E, Tohno E, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239(2):341–350. doi:10.1148/radiol.239104167616484352
   PubMed Web of Science ®Google Scholar
• Gennisson JL, Deffieux T, Fink M, Tanter M. Ultrasound elastography: principles and techniques. Diagn Interv Imaging. 2013;94(5):487–495. doi:10.1016/j.diii.2013.01.02223619292
   PubMedGoogle Scholar
• Sigrist RMS, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound elastography: review of techniques and clinical applications. Theranostics. 2017;7(5):1303–1329. doi:10.7150/thno.1865028435467
   PubMed Web of Science ®Google Scholar
• Gu LS, Zhang R, Wang Y, et al. Characteristics of contrast-enhanced ultrasonography and strain elastography of locally advanced breast cancer. J Thorac Dis. 2019;11(12):5274–5289. doi:10.21037/jtd.2019.11.5232030245
   PubMed Web of Science ®Google Scholar
• Hayashi M, Yamamoto Y, Ibusuki M, et al. Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. Ann Surg Oncol. 2012;19(9):3042–3049. doi:10.1245/s10434-012-2343-122476757
   PubMed Web of Science ®Google Scholar
• Ricci P, Maggini E, Mancuso E, Lodise P, Cantisani V, Catalano C. Clinical application of breast elastography: state of the art. Eur J Radiol. 2014;83(3):429–437. doi:10.1016/j.ejrad.2013.05.00723787274
   PubMed Web of Science ®Google Scholar
• Cosgrove DO, Berg WA, Doré CJ, et al. Shear wave elastography for breast masses is highly reproducible. Eur Radiol. 2012;22(5):1023–1032. doi:10.1007/s00330-011-2340-y22210408
   PubMed Web of Science ®Google Scholar
• Chang JM, Moon WK, Cho N, et al. Clinical application of shear wave elastography (SWE) in the diagnosis of benign and malignant breast diseases. Breast Cancer Res Treat. 2011;129(1):89–97. doi:10.1007/s10549-011-1627-721681447
   PubMed Web of Science ®Google Scholar
• Evans A, Whelehan P, Thomson K, et al. Invasive breast cancer: relationship between shear-wave elastographic findings and histologic prognostic factors. Radiology. 2012;263(3):673–677. doi:10.1148/radiol.1211131722523322
   PubMed Web of Science ®Google Scholar
• Chang JM, Park IA, Lee SH, et al. Stiffness of tumours measured by shear-wave elastography correlated with subtypes of breast cancer. Eur Radiol. 2013;23(9):2450–2458. doi:10.1007/s00330-013-2866-223673574
   PubMed Web of Science ®Google Scholar
• Evans A, Armstrong S, Whelehan P, et al. Can shear-wave elastography predict response to neoadjuvant chemotherapy in women with invasive breast cancer? Br J Cancer. 2013;109(11):2798–2802. doi:10.1038/bjc.2013.66024169359
   PubMed Web of Science ®Google Scholar
• Jing H, Cheng W, Li ZY, et al. Early evaluation of relative changes in tumor stiffness by shear wave elastography predicts the response to neoadjuvant chemotherapy in patients with breast cancer. J Ultrasound Med. 2016;35(8):1619–1627. doi:10.7863/ultra.15.0805227302898
   PubMed Web of Science ®Google Scholar
• Wojcinski S, Farrokh A, Hille U, et al. The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases. Int J Womens Health. 2011;3:337–346. doi:10.2147/IJWH.S2391822114526
   PubMedGoogle Scholar
• van Egdom LSE, Lagendijk M, Heijkoop EHM, et al. Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? - RESPONDER trial. Eur J Radiol. 2018;104:94–100. doi:10.1016/j.ejrad.2018.05.00529857873
   PubMed Web of Science ®Google Scholar
• Wang X, Huo L, He Y, et al. Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound. Chin J Cancer Res. 2016;28(5):478–485. doi:10.21147/j.issn.1000-9604.2016.05.0227877006
   PubMed Web of Science ®Google Scholar
• Folkman J, Merler E, Abernathy C, Williams G. Isolation of a tumor factor responsible for angiogenesis. J Exp Med. 1971;133(2):275–288. doi:10.1084/jem.133.2.2754332371
   PubMed Web of Science ®Google Scholar
• Lee SW, Choi HY, Baek SY, Lim SM. Role of color and power Doppler imaging in differentiating between malignant and benign solid breast masses. J Clin Ultrasound. 2002;30(8):459–464. doi:10.1002/jcu.1010012242733
   PubMed Web of Science ®Google Scholar
• Demi L, Verweij MD, Van Dongen KW. Parallel transmit beamforming using orthogonal frequency division multiplexing applied to harmonic imaging–a feasibility study. IEEE Trans Ultrason Ferroelectr Freq Control. 2012;59(11):2439–2447. doi:10.1109/TUFFC.2012.247623192807
   PubMed Web of Science ®Google Scholar
• Chang RF, Huang SF, Moon WK, Lee YH, Chen DR. Computer algorithm for analysing breast tumor angiogenesis using 3-D power Doppler ultrasound. Ultrasound Med Biol. 2006;32(10):1499–1508. doi:10.1016/j.ultrasmedbio.2006.05.02917045870
   PubMed Web of Science ®Google Scholar
• Shia WC, Huang YL, Wu HK, Chen DR. Using flow characteristics in three-dimensional power Doppler ultrasound imaging to predict complete responses in patients undergoing neoadjuvant chemotherapy. J Ultrasound Med. 2017;36(5):887–900. doi:10.7863/ultra.16.0207828109009
   PubMed Web of Science ®Google Scholar
• Jia WR, Tang L, Wang DB, et al. Three-dimensional contrast-enhanced ultrasound in response assessment for breast cancer: a comparison with dynamic contrast-enhanced magnetic resonance imaging and pathology. Sci Rep. 2016;6:33832. doi:10.1038/srep3383227652518
   PubMed Web of Science ®Google Scholar
• Matsuda N, Kida K, Ohde S, et al. Change in sonographic brightness can predict pathological response of triple-negative breast cancer to neoadjuvant chemotherapy. Breast Cancer. 2018;25(1):43–49. doi:10.1007/s12282-017-0782-z28536943
   PubMed Web of Science ®Google Scholar
• Dobruch-Sobczak K, Piotrzkowska-Wróblewska H, Klimonda Z, Roszkowska-Purska K, Litniewski J. Ultrasound echogenicity reveals the response of breast cancer to chemotherapy. Clin Imaging. 2019;55:41–46. doi:10.1016/j.clinimag.2019.01.02130739033
   PubMed Web of Science ®Google Scholar
• Alam SK, Feleppa EJ, Rondeau M, Kalisz A, Garra BS. Ultrasonic multi-feature analysis procedure for computer-aided diagnosis of solid breast lesions. Ultrason Imaging. 2011;33(1):17–38. doi:10.1177/01617346110330010221608446
   PubMed Web of Science ®Google Scholar
• Sadeghi-Naini A, Papanicolau N, Falou O, et al. Quantitative ultrasound evaluation of tumor cell death response in locally advanced breast cancer patients receiving chemotherapy. Clin Cancer Res. 2013;19(8):2163–2174. doi:10.1158/1078-0432.CCR-12-296523426278
   PubMed Web of Science ®Google Scholar
• DiCenzo D, Quiaoit K, Fatima K, et al. Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: results from multi-institutional study. Cancer Med. 2020;9(16):5798–5806. doi:10.1002/cam4.325532602222
   PubMed Web of Science ®Google Scholar
• Sannachi L, Gangeh M, Tadayyon H, et al. Breast cancer treatment response monitoring using quantitative ultrasound and texture analysis: comparative analysis of analytical models. Transl Oncol. 2019;12(10):1271–1281.31325763
   PubMed Web of Science ®Google Scholar
• Tadayyon H, Gangeh M, Sannachi L, et al. A priori prediction of breast tumour response to chemotherapy using quantitative ultrasound imaging and artificial neural networks. Oncotarget. 2019;10(39):3910–3923. doi:10.18632/oncotarget.2699631231468
   PubMedGoogle Scholar
• Piotrzkowska-Wróblewska H, Dobruch-Sobczak K, Klimonda Z, et al. Monitoring breast cancer response to neoadjuvant chemotherapy with ultrasound signal statistics and integrated backscatter. PLoS One. 2019;14(3):e0213749. doi:10.1371/journal.pone.021374930870478
   PubMed Web of Science ®Google Scholar
• Choe R, Durduran T. Diffuse optical monitoring of the neoadjuvant breast cancer therapy. IEEE J Sel Top Quantum Electron. 2012;18(4):1367–1386. doi:10.1109/JSTQE.2011.217796323243386
   PubMed Web of Science ®Google Scholar
• Zhi W, Liu G, Chang C, et al. Predicting treatment response of breast cancer to ne foadjuvant chemotherapy using ultrasound-guided diffuse optical tomography. Transl Oncol. 2018;11(1):56–64. doi:10.1016/j.tranon.2017.10.01129175630
   PubMed Web of Science ®Google Scholar
• Tromberg BJ, Cerussi A, Shah N, et al. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy. Breast Cancer Res. 2005;7(6):279–285. doi:10.1186/bcr135816457705
   PubMed Web of Science ®Google Scholar
• Zhu Q, Cronin EB, Currier AA, et al. Benign versus malignant breast masses: optical differentiation with US-guided optical imaging reconstruction. Radiology. 2005;237(1):57–66. doi:10.1148/radiol.237104123616183924
   PubMed Web of Science ®Google Scholar
• Fournier LS, Vanel D, Athanasiou A, et al. Dynamic optical breast imaging: a novel technique to detect and characterize tumor vessels. Eur J Radiol. 2009;69(1):43–49. doi:10.1016/j.ejrad.2008.07.03818829193
   PubMed Web of Science ®Google Scholar
• Ueda S, Nakamiya N, Matsuura K, et al. Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast. BMC Cancer. 2013;31(13):514. doi:10.1186/1471-2407-13-514
   Web of Science ®Google Scholar
• Xu C, Vavadi H, Merkulov A, et al. Ultrasound-guided diffuse optical tomography for predicting and monitoring neoadjuvant chemotherapy of breast cancers: recent progress. Ultrason Imaging. 2016;38(1):5–18.25887527
   PubMed Web of Science ®Google Scholar